Neurological, Cognitive, and Systemic Manifestations of Post-COVID Syndrome: A Cross-Sectional Study in a Caucasian Cohort
DOI:
https://doi.org/10.52340/GBMN.2026.01.01.174Keywords:
Ageusia, Anosmia, Caucasian population, Clinical phenotype, Cognitive impairment, Cross-sectional study, Disease severity, Fatigue, Long COVID, Neurological symptoms, Neuropsychology, Post-COVID syndromeAbstract
BACKGROUND. Post-COVID syndrome is increasingly recognized as a heterogeneous clinical condition characterized by persistent neurological, cognitive, and systemic symptoms. While individual manifestations have been widely reported, the overall clinical phenotype and symptom distribution remain insufficiently characterized, particularly in specific regional populations. OBJECTIVES. To characterize the neurological, cognitive, and systemic manifestations of post-COVID syndrome in a Caucasian cohort and to evaluate their association with acute COVID-19 severity. METHODS. This cross-sectional study included 360 individuals with prior SARS-CoV-2 infection and persistent post-COVID symptoms. Demographic, clinical, and disease-related variables were collected, including disease severity, hospitalization status, and comorbidities. Neurological, cognitive, and systemic symptoms were assessed using patient-reported outcomes and clinical evaluation. Neuropsychological status was evaluated using validated instruments, including PHQ-9, BDI, STAI, and MoCA. Statistical analyses were performed to describe symptom distribution and to assess differences across disease severity groups. RESULTS. Neurological and systemic symptoms were highly prevalent, with anosmia (78.9%) and ageusia (59.4%) representing the most common manifestations. Cognitive symptoms were also frequent, including memory complaints (45.8%) and executive dysfunction (30.8%). Fatigue was reported in 42.8% of participants. Symptom burden varied according to disease severity, with significantly higher prevalence of cognitive impairment, fatigue, and neuropathic symptoms observed in patients with severe acute COVID-19 (p < 0.05). In contrast, sensory symptoms such as anosmia and ageusia were distributed relatively evenly across severity groups. Neurological and systemic symptoms demonstrated substantial heterogeneity across the study population. CONCLUSIONS. A heterogeneous clinical phenotype with a high prevalence of sensory, cognitive, and systemic symptoms characterizes Post-COVID syndrome. Disease severity is associated with increased burden of cognitive and systemic manifestations, while sensory dysfunction appears independent of severity. These findings highlight the importance of comprehensive clinical assessment and support the need for multidisciplinary management strategies in post-COVID populations.References
Maamar M, Artime A, Pariente E, et al. Post-COVID-19 syndrome, low-grade inflammation and inflammatory markers: a cross-sectional study. Curr Med Res Opin. 2022;38(6):901-909. doi:10.1080/03007995.2022.2042991.
Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020;395(10223):507-513. doi:10.1016/S0140-6736(20)30211-7.
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497-506. doi:10.1016/S0140-6736(20)30183-5.
Vints WAJ, Valatkevičienė K, Levin O, et al. Hippocampal neurometabolic and structural changes from pre-to post-COVID-19: A case-series study. Magn Reson Imaging. 2024;109:249-255. doi:10.1016/j.mri.2024.03.032.
Vlaming-van Eijk LE, Bulthuis MLC, van der Gun BTF, et al. Systemic oxidative stress associates with the development of post-COVID-19 syndrome in non-hospitalized individuals. Redox Biol. 2024;76. doi:10.1016/j.redox.2024.103310.
Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, Cook JR, Nordvig AS, Shalev D, Sehrawat TS, Ahluwalia N, Bikdeli B, Dietz D, Der-Nigoghossian C, Liyanage-Don N, Rosner GF, Bernstein EJ, Mohan S, Beckley AA, Seres DS, Choueiri TK, Uriel N, Ausiello JC, Accili D, Freedberg DE, Baldwin M, Schwartz A, Brodie D, Garcia CK, Elkind MSV, Connors JM, Bilezikian JP, Landry DW, Wan EY. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601-615. doi:10.1038/s41591-021-01283-z
Kankaya S, Yavuz F, Tari A, et al. Glutathione-related antioxidant defence, DNA damage, and DNA repair in patients suffering from post-COVID conditions. Mutagenesis. 2023;38(4):216-226. doi:10.1093/mutage/gead021.
Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, Rodrigues NB, Subramaniapillai M, Di Vincenzo JD, Cao B, Lin K, Mansur RB, Ho RC, Rosenblat JD, Miskowiak KW, Vinberg M, Maletic V, McIntyre RS. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav Immun. 2022;101:93-135. doi:10.1016/j.bbi.2021.12.020.
Davies NG, Klepac P, Liu Y, et al. Age-dependent effects in the transmission and control of COVID-19 epidemics. Nat Med. 2020;26(8):1205-1211. doi:10.1038/S41591-020-0962-9.
Jin X, Lian JS, Hu JH, et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020;69(6):1002-1009. doi:10.1136/gutjnl-2020-320926.
Han AY, Mukdad L, Long JL, Lopez IA. Anosmia in COVID-19: Mechanisms and significance. Chem Senses. 2020;45(6):423-428. doi:10.1093/chemse/bjaa040.
Boscolo-Rizzo P, Borsetto D, Fabbris C, et al. Evolution of Altered Sense of Smell or Taste in Patients with Mildly Symptomatic COVID-19. JAMA Otolaryngol Head Neck Surg. 2020;146(8):1-5. doi:10.1001/JAMAOTO.2020.1379.
Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102-e107. doi:10.1016/S1473-3099(21)00703-9.
Venkataramani V, Winkler F. Cognitive Deficits in Long Covid-19. New England Journal of Medicine. 2022;387(19):1813-1815. doi:10.1056/nejmcibr2210069.
Premraj L, Kannapadi N V., Briggs J, et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. J Neurol Sci. 2022;434. doi:10.1016/j.jns.2022.120162.
Graham EL, Clark JR, Orban ZS, Lim PH, Szymanski AL, Taylor C, DiBiase RM, Jia DT, Balabanov R, Ho SU, Batra A. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 "long haulers". Ann Clin Transl Neurol. 2021;8(5):1073-1085. doi:10.1002/acn3.51350.